|
⚲
|
| Keyboard |
| Andrew Rappaport | |
|---|---|
| Firm | |
| Address | c/o Olema Pharmaceuticals, Inc 780 Brannan Street San Francisco, CA 94103 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | 021-531835 | Director | 250.0 M of 250.0 M |
||
| Olema Pharmaceuticals Inc | 021-492146 | Director | 130.0 M of 130.0 M |
||
| Olema Pharmaceuticals Inc | 021-377769 | Director | 87.4 M of 87.4 M |
||
| Olema Pharmaceuticals Inc | 021-363815 | Director | 53.9 M of 55.4 M |
||
| Olema Pharmaceuticals Inc | 021-320082 | Director | 6.1 M of 6.1 M |
||
| Luxtera Inc | 021-38976 | Director | 29.9 M of 29.9 M |
||
| August Capital Master Management Company LLC | |||||
| August Capital Strategic Partners V LP | 021-131432 | Executive Officer | 5.5 M of 5.5 M |
3.3 M | |
| August Capital V LP | 021-125226 | Executive Officer | of 400.0 M |
269.5 M | |
| August Capital V Special Opportunities LP | 021-125227 | Executive Officer | of 250.0 M |
35.3 M | |